Integral Molecular
- Biotech or pharma, therapeutic R&D
Integral Molecular discovers and develops antibodies against under-exploited membrane protein targets, including GPCRs, ion channels, and transporters, for partnering of first-in-class MAbs in immuno-oncology, immunity, metabolic diseases and pain.
Address
PhiladelphiaPennsylvania
United States